|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2007-11-28
|
|
pubmed:abstractText |
Treatment-naïve participants were randomized to three antiretroviral strategies (all with nucleoside reverse transcriptase inhibitor [NRTI] background): protease inhibitor (PI), non-nucleoside reverse transcriptase inhibitor (NNRTI), or PI+NNRTI. The strategies were compared for drug resistance at first virologic failure (VF; HIV RNA >1000 copies/mL). The impact of resistance on AIDS or death was determined.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1528-4336
|
|
pubmed:author |
pubmed-author:BaxterJohn DJD,
pubmed-author:Berg-WolfMary van denM,
pubmed-author:HullsiekKatherine HupplerKH,
pubmed-author:KozarMichael PMP,
pubmed-author:MacarthurRodger DRD,
pubmed-author:NovakRichard MRM,
pubmed-author:PengGraceG,
pubmed-author:TelzakEdward EEE,
pubmed-author:Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA),
pubmed-author:UyJonathanJ,
pubmed-author:XiangYingY
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
357-70
|
|
pubmed:meshHeading |
pubmed-meshheading:18042501-Anti-HIV Agents,
pubmed-meshheading:18042501-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:18042501-Disease Progression,
pubmed-meshheading:18042501-Drug Resistance, Viral,
pubmed-meshheading:18042501-HIV,
pubmed-meshheading:18042501-HIV Infections,
pubmed-meshheading:18042501-Humans,
pubmed-meshheading:18042501-Incidence,
pubmed-meshheading:18042501-Patient Compliance,
pubmed-meshheading:18042501-Risk Factors,
pubmed-meshheading:18042501-Time Factors,
pubmed-meshheading:18042501-Treatment Outcome
|
|
pubmed:articleTitle |
The Incidence of HIV drug resistance and its impact on progression of HIV disease among antiretroviral-naïve participants started on three different antiretroviral therapy strategies.
|
|
pubmed:affiliation |
Yale University School of Medicine and VA CT Healthcare System, New Haven, Connecticut 06510, USA. Michael.Kozal@yale.edu
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Research Support, N.I.H., Extramural
|
